Vertex Pharmaceuticals Incorporated (VRTX) gains on earnings misses
Vertex Pharmaceuticals Incorporated (VRTX) gains 0.5% after earnings misses, as investors weigh the latest results against the stock’s modest move higher.

Vertex Pharmaceuticals Incorporated (VRTX) Earnings Miss, Stock Gains
Vertex Pharmaceuticals Incorporated (VRTX) missed quarterly EPS estimates at $4.76 versus $4.82, but beat revenue estimates at $3.44B versus $3.42B, sending shares up 0.51% to $561.75 in after-hours trading.
Key Numbers
- EPS: $4.76 actual versus $4.82 estimated, a miss.

